SGP
SpyGlass Pharma, Inc.
$19.15
-0.32 (-1.64%)
At close · Jul 2
Market Cap
$640.25M
Shares
33,433,355
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$19.15
Open$19.47
Day$18.81–20.02
52W$17.06–32.44
Avg vol 30d123K
Short int1.0M · 3.0% float · 14.3d
Short vol51%
Last earningsMay 14, 2026
DataFeb 2026–Jul 2026
Filing10-Q · May 14
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 50-day avg
−9% below
◦
RSI (14)
46 · neutral
+
MACD trend
positive
−
52-week position
14% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50/200-day averages unavailable
+
Institutional flow
+34 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
3.03% of float · ▼ -11.6% MoM · 14.3 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
34 holders — 13F breadth
Fundamentals
Weak
−
EPS growth
−10% Y/Y
−
Free cash flow
$-33.5M
+
Balance sheet
net cash $96.4M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 50-day avg
−9% below
Bearish
RSI (14)
46 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
14% · near low
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+34 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.03% of float · ▼ -11.6% MoM · 14.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
34 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $17
Now $19 · 14%
52-wk high $32
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SGP
this stock
SpyGlass Pharma, Inc.
|
$640.25M | — | — | — | 3.0% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SGP | +1.8% | +3.2% | — | -14.0% | — |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +0.4% | +4.4% | — | -13.7% | — |